ORBIMED ADVISORS LLC – Boston Scientific Corporation Transaction History
ORBIMED ADVISORS LLC portfolio value:
$150.97M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+3.92%
quarter
Boston Scientific Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -10.79% | -471.3K shares | -11.87M | $38.73 | 3.89M |
Q2 2022 | share | Decrease | -5.00% | -230K shares | -40.86M | $37.27 | 4.36M |
Q1 2022 | share | Decrease | -17.16% | -952.8K shares | -32.15M | $44.29 | 4.59M |
Q4 2021 | share | Decrease | -4.82% | -281.3K shares | -17.25M | $42.99 | 5.55M |
Q3 2021 | share | Decrease | -15.71% | -1.08M shares | -42.80M | $43.39 | 5.83M |
Q3 2021 | call | Decrease | -100.00% | -250K shares | -10.69M | $43.39 | 0 |
Q2 2021 | share | 0.00% | 0 shares | 28.44M | $42.76 | 6.92M | |
Q2 2021 | call | Increase | 0.00% | 250K shares | 10.69M | $42.76 | 250K |
Q1 2021 | share | Increase | +6.10% | 397.6K shares | 32.97M | $38.65 | 6.92M |
Q4 2020 | share | Increase | +34.57% | 1.67M shares | 49.28M | $35.95 | 6.52M |
Q3 2020 | share | 0.00% | 0 shares | 15.02M | $38.21 | 4.84M | |
Q2 2020 | share | 0.00% | 0 shares | 12.02M | $35.11 | 4.84M | |
Q1 2020 | share | Increase | +3.69% | 172.5K shares | -53.22M | $32.63 | 4.84M |
Q4 2019 | share | Decrease | -11.27% | -593.9K shares | -2.98M | $45.22 | 4.67M |
Q3 2019 | share | Decrease | -21.97% | -1.48M shares | -75.83M | $40.69 | 5.26M |
Q2 2019 | share | Increase | +16.62% | 962.1K shares | 67.98M | $42.98 | 6.75M |
Q1 2019 | call | Decrease | -100.00% | -250K shares | -8.83M | $38.38 | 0 |
Q1 2019 | share | 0.00% | 0 shares | 17.60M | $38.38 | 5.79M | |
Q4 2018 | call | Increase | 0.00% | 250K shares | 8.83M | $35.34 | 250K |
Q4 2018 | share | Decrease | -26.37% | -2.07M shares | -98.13M | $35.34 | 5.79M |
Q3 2018 | share | Decrease | -17.87% | -1.71M shares | -10.32M | $38.5 | 7.86M |
Q2 2018 | share | Decrease | -7.74% | -803.1K shares | 29.57M | $32.7 | 9.57M |
Q1 2018 | share | Decrease | -0.08% | -8.80K shares | 26.03M | $27.32 | 10.37M |
Q4 2017 | share | Decrease | -22.47% | -3.01M shares | -133.30M | $24.79 | 10.38M |
Q3 2017 | share | Decrease | -6.97% | -1.00M shares | -8.37M | $29.17 | 13.39M |
Q2 2017 | share | Decrease | -5.95% | -911.4K shares | 18.37M | $27.72 | 14.4M |
Q1 2017 | share | Decrease | -7.24% | -1.19M shares | 23.75M | $24.87 | 15.31M |
Q4 2016 | share | Decrease | -4.09% | -704.8K shares | -52.59M | $21.63 | 16.50M |
Q3 2016 | share | Decrease | -25.58% | -5.91M shares | -130.89M | $23.8 | 17.21M |
Q2 2016 | share | Increase | +2.89% | 649.5K shares | 117.68M | $23.37 | 23.12M |
Q1 2016 | share | Decrease | -7.99% | -1.95M shares | -27.66M | $18.81 | 22.47M |